biomarker-driven treatment strategies for her2 g/gej junction cancer
Published 4 weeks ago • 23 plays • Length 1:27Download video MP4
Download video MP3
Similar videos
-
1:43
biomarker-driven treatments for esophageal squamous cell carcinoma
-
1:09
dr. ahn on biomarker-driven strategies in gastric/gej cancers
-
35:36
personalized treatment of advanced her2-negative gastric or gastroesophageal junction cancer
-
1:28
advances in biomarker-directed therapies for gastric cancer
-
3:18
pangea: personalized treatment strategy for patients with metastatic gastroesophageal adenocarcinoma
-
7:30
navigating treatment paths: selection and sequencing in biomarker-driven combination regimens for...
-
2:45
current and future biomarkers for gastroesophageal cancer
-
2:46
exploring real-world biomarker testing for patients with advanced esophageal cancers
-
23:25
advances in esophageal cancer: current and future strategies
-
0:29
biomarker testing in gastroesophageal cancer
-
18:59
controversy debate 2: selecting optimal treatments for esophagus cancer - whom to operate upon?
-
1:20
dr tolaney on the potential role for biomarkers in early-stage her2 breast cancer
-
28:57
for pharmacists: evolution of her2-targeted therapy in gastroesophageal adenocarcinoma
-
25:50
advances in esophageal cancer: current and future strategies
-
2:17
her2: a driver of breast cancer
-
6:31
checkmate 649 biomarker analyses of nivo ipi vs chemo for patients with gc/gejc/eac
-
28:57
evolution of her2-targeted therapy in gastroesophageal adenocarcinoma
-
56:48
immunotherapy for gastroesophageal cancer